| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.28 | 7e-20 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-14 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.24 | 4e-14 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-13 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-13 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-11 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-10 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-10 |